» Articles » PMID: 24642794

High Mortality in Adults Hospitalized for Active Tuberculosis in a Low HIV Prevalence Setting

Overview
Journal PLoS One
Date 2014 Mar 20
PMID 24642794
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence.

Methods: A retrospective cohort study was conducted on all adults hospitalized for pulmonary and/or extrapulmonary tuberculosis in an acute-care hospital in Hong Kong during a two-year period. Microscopy and solid-medium culture were routinely performed. The diagnosis of tuberculosis was made by: (1) positive culture of M. tuberculosis, (2) positive M. tuberculosis PCR result, (3) histology findings of tuberculosis infection, and/or (4) typical clinico-radiological manifestations of tuberculosis which resolved after anti-TB treatment, in the absence of alternative diagnoses. Time to treatment ('early', started during initial admission; 'late', subsequent periods), reasons for delay, and short- and long-term survival were analyzed.

Results: Altogether 349 patients were studied [median(IQR) age 62(48-77) years; non-HIV immunocompromised conditions 36.7%; HIV/AIDS 2.0%]. 57.9%, 16.3%, and 25.8% had pulmonary, extrapulmonary, and pulmonary-extrapulmonary tuberculosis respectively. 58.2% was smear-negative; 0.6% multidrug-resistant. 43.4% developed hypoxemia. Crude 90-day and 1-year all-cause mortality was 13.8% and 24.1% respectively. 57.6% and 35.8% received 'early' and 'late' treatment respectively, latter mostly culture-guided [median(IQR) intervals, 5(3-9) vs. 43(25-61) days]. Diagnosis was unknown before death in 6.6%. Smear-negativity, malignancy, chronic lung diseases, and prior exposure to fluoroquinolones (adjusted-OR 10.6, 95%CI 1.3-85.2) delayed diagnosis of tuberculosis. Failure to receive 'early' treatment independently predicted higher mortality (Cox-model, adjusted-HR 1.8, 95%CI 1.1-3.0).

Conclusions: Mortality of hospitalized tuberculosis patients is high. Newer approaches incorporating methods for rapid diagnosis and initiation of anti-tuberculous treatment are urgently required to improve outcomes.

Citing Articles

Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths.

Jeong Y, Park J, Kim H, Min J, Ko Y, Oh J Front Public Health. 2023; 11:1207284.

PMID: 37719730 PMC: 10502314. DOI: 10.3389/fpubh.2023.1207284.


A clinical indicator-based prognostic model predicting treatment outcomes of pulmonary tuberculosis: a prospective cohort study.

Zhan M, Xue H, Wang Y, Wu Z, Wen Q, Shi X BMC Infect Dis. 2023; 23(1):101.

PMID: 36803117 PMC: 9940065. DOI: 10.1186/s12879-023-08053-x.


Incidence, duration and risk factors associated with delayed and missed diagnostic opportunities related to tuberculosis: a population-based longitudinal study.

Miller A, Arakkal A, Koeneman S, Cavanaugh J, Gerke A, Hornick D BMJ Open. 2021; 11(2):e045605.

PMID: 33602715 PMC: 7896623. DOI: 10.1136/bmjopen-2020-045605.


Diagnostic value of miR-145 and its regulatory role in macrophage immune response in tuberculosis.

Fu Y, Yang X, Chen H, Lu Y Genet Mol Biol. 2020; 43(2):e20190238.

PMID: 32614357 PMC: 7263433. DOI: 10.1590/1678-4685-GMB-2019-0238.


Adherence to Treatment Guideline Improves Patient Outcomes in a Prospective Cohort of Adults Hospitalized for Community-Acquired Pneumonia.

Lui G, To H, Lee N, Chan R, Li T, Wong R Open Forum Infect Dis. 2020; 7(5):ofaa146.

PMID: 32467825 PMC: 7243378. DOI: 10.1093/ofid/ofaa146.


References
1.
Malbasa M, Pesut D . Is there delay in diagnosis of pulmonary tuberculosis in an intermediate-to-low TB incidence setting. Pneumologia. 2011; 60(3):138-42. View

2.
Vant Hoog A, Williamson J, Sewe M, Mboya P, Odeny L, Agaya J . Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya. Int J Tuberc Lung Dis. 2012; 16(12):1649-56. DOI: 10.5588/ijtld.12.0135. View

3.
Yen Y, Yen M, Shih H, Deng C . Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan. Trans R Soc Trop Med Hyg. 2012; 106(5):303-8. DOI: 10.1016/j.trstmh.2012.01.011. View

4.
Lui G, Lee N, Cheung S, Lam J, Wong B, Choi K . Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting. J Infect. 2011; 62(6):440-7. DOI: 10.1016/j.jinf.2011.04.011. View

5.
Marks S, Magee E, Robison V . Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus. Int J Tuberc Lung Dis. 2011; 15(4):465-70. PMC: 5451101. DOI: 10.5588/ijtld.10.0259. View